• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH BLOOD GROUPING REAGENT IH-CARD ABO/D(DVI+)+REV A1,B; IH-CARD ABO/D(DVI+)+REV A1,B; 48 CARDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH BLOOD GROUPING REAGENT IH-CARD ABO/D(DVI+)+REV A1,B; IH-CARD ABO/D(DVI+)+REV A1,B; 48 CARDS Back to Search Results
Catalog Number 813121100
Device Problems False Positive Result (1227); Defective Device (2588)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/14/2020
Event Type  malfunction  
Manufacturer Narrative
This is our combined initial and final report on this incident.
 
Event Description
The customer reported a false positive result of one patient sample ((b)(6)) with the anti-b and the control of the ih-card abo/d(dvi+)+rev.A1, b on ih-1000 (b)(4).The customer stated that the manual testing with the same card lot and same specimen yielded a correct result.Due to the discrepancy between forward and reverse typing and the false positive reaction with the control the ih-1000 stated "a discrepancy has been identified" and no incorrect result was released.Within the investigation of the trace files we became aware that another sample showed a similar issue on (b)(6) 2020: sample (b)(6) showed a false positive result with the anti-b and the control of the ih-card abo/d(dvi+)+rev.A1, b lot 8924050 on ih-1000 (b)(4).The customer returned trace files for investigation, but neither the complaint samples of the supposedly defective products nor the patient samples that had caused the false positive results.Therefore our quality control laboratory tested their retention samples of both supposedly defective lots with different donor samples on ih-1000.All positive and negative results were correct.We did not observe any false positive reaction.The traces files of the affected ih-1000 have been analysed.The outcome of the investigation was: in the data provided by the customer, we could not check events regarding sample ((b)(6)) tested on (b)(6) 2020.However, we have been able to carry out checks on another sample ((b)(6)) tested on (b)(6) 2020, and which shows similar issue to that one described in the case.On (b)(6), tests were performed on the ih-1000 device's left robot pipettor side.We could confirm the customer's findings on the sample # (b)(6).During forward test on cards checked, wells were dispensed from the control well to anti-a.This allows to exclude inter well carry over, at least for ctrl well which was the first dispensed.In the provided data, we could also see that there was another sample processed in the same batch.That sample is identified with the number # (b)(6) and was dispensed on ih-card # (b)(6).This patient is blood group b and has anti-a antibodies.We assume that, as the forward test was performed first on the sample (b)(6), there were anti-a antibodies still stickled to the needle during red blood cells dilution of the following sample # (b)(6).So anti-a antibodies could have sensitized that following sample red cells and explain why there were false positive wells returned.As a preventive action, we highly recommend to the customer: to check the device's left robot pipettor needle and adjust it as recommended in service manual; it should be replaced if it was bent or the coating was damaged.Washing pot must be also be cleaned, without any sign of leakage.Testing by our quality control laboratory confirmed that the allegedly defective lots of ih-card abo/d(dvi+)+rev.A1, b function correctly.The false positive reactions might be caused by a contamination.Therefore a maintenance of the instrument is highly recommended.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lots.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLOOD GROUPING REAGENT IH-CARD ABO/D(DVI+)+REV A1,B
Type of Device
IH-CARD ABO/D(DVI+)+REV A1,B; 48 CARDS
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, 63303
GM  63303
Manufacturer (Section G)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, 63303
GM   63303
Manufacturer Contact
martina benkert
industriestrasse 1
dreieich, hessen 63303
GM   63303
MDR Report Key9956843
MDR Text Key242608256
Report Number9610824-2020-00015
Device Sequence Number1
Product Code KSZ
UDI-Device Identifier07611969952106
UDI-Public(01)07611969952106(17)200909(10)8919060
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/09/2020
Device Catalogue Number813121100
Device Lot Number8919060
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/16/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-